Background
redensity 2 left top
redensity 2  bottom
product

HYALURONIC ACID + LIDOCAINE INJECTION

TEOSYAL RHA® 1

For the treatment of fine wrinkles in the face, neck and décolleté

Do you feel dissatisfied with the current solutions to treat the most delicate areas like the tricky barcode, the neck and décolleté? 

TEOSYAL RHA® 1 is recommended to treat dynamic superficial wrinkles (face, neck and décolleté) and especially the barcode or smoker's lines, a very sensitive and dynamic area, for patients willing to get natural-looking results.

CHAMP A RENDRE OPTIONNEL For the treatment of fine wrinkles in the face, neck and décolleté

  • TEOSYAL RHA® 1
«
CHAMP A RENDRE OPTIONNEL Excellent product, an innovation for very fine wrinkles and barcode - very natural - very discreet. »

CHAMP A RENDRE OPTIONNEL

Indicated for the even filling of lines, superficial wrinkles, fine wrinkles and skin cracks, and for the correction of areas of skin that are wizened or marked by signs of ageing on the face, neck and neckline.
It is also indicated for filling wrinkles and skin folds (including circles under the eyes).

CHAMP A RENDRE OPTIONNEL

Dr Jean-Louis Sebagh, France & UK


Before & after

CHAMP A RENDRE OPTIONNEL

ff

Before

ff

After

CHAMP A RENDRE OPTIONNEL Courtesy of Prof.Giuseppe Sito

ABOUT TEOSYAL RHA® 1

  • Product Benefits
  • Indications
  • Technology
  1. Study 1403: Unpublished study, efficacy and safety of an injection-assisted device compared to a manual injection device in the treatment of the upper lip area, RHA®1 .
    A split-face, double-blinded, single-centre, prospective, randomized, controlled trial.

  2. TEOSYAL RHA® 1 is indicated for the treatment of all fine wrinkles in the face, neck and décolleté. It is especially valued for treating the perioral region, and notably the “barcode” lines, using the Dynamic Decoding technique described by Drs. Redka-Swoboda and Carey and Prof. Sito.

    Principal characteristics:

    • Mix of non crosslinked HA and crosslinked HA
    • HA concentration: 15 mg/mL
    • Degree of modification: 1.9%
    • Lidocaine: 0.3%
    • Syringe volume: 1 mL
    • Needle: 30G x 1/2"
    • Injection depth: mid-dermis
  3. 1st RESILIENT HYALURONIC ACID DEDICATED TO FACIAL DYNAMICS

    Resulting from xx years of process optimization (6 patents families filed)*, our "Preserved Network" technology allows us to use low amounts of BDDE** and prepare gels with: 

    • Long HA chains (High Molecular Weight)
    • A low degree of modification***


    *WO2010131175, WO2012077054, WO2012077055, WO2014064633, WO2014064632, WO2016096920
    ** BDDE: 1,4-Butanediol Diglycidyl Ether
    ***TEOXANE Laboratories. Data on file, measurement by an independent laboratory of the HA Degree of Modification by 1H NMR

TEOSYAL RHA® 

CHAMP A RENDRE OPTIONNEL

See more

Find a practitioner

Required fields*

I agree to receive exclusive offers and the latest news from Hyaluronic-acid.com
Choose your country

Close

close
Europe

France

UK

Germany

Italy

Poland

Switzerland

Spain

Russia

International

English

French

Asia Pacific

Australia

Malaysia

Come back to consumer area

You are switching to our professional universe

close